AU Stock MarketDetailed Quotes
AGN Argenica Therapeutics Ltd
- 0.830
- -0.015-1.78%
20min DelayMarket Closed Aug 16 15:59 AET
105.52MMarket Cap-15090P/E (Static)
0.880High0.815Low225.45KVolume0.862Open0.845Pre Close191.95KTurnover0.98552wk High0.24%Turnover Ratio127.13MShares0.29552wk Low-0.051EPS TTM78.41MFloat Cap1.020Historical HighLossP/E (Static)94.48MShs Float0.250Historical Low-0.055EPS LYR7.69%Amplitude--Dividend TTM15.96P/B1Lot Size--Div YieldTTM
About Argenica Therapeutics Ltd Company
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.
Company Profile
SymbolAGN
Company NameArgenica Therapeutics Ltd
Founded2019
MarketASX
Fiscal Year Ends06-30
Address117 Broadway Unit 4
CityNedlands
CountryAustralia
Zip Code6009
Phone+61 893293396
Websitehttps://www.argenica.com.au
Share RegistryLINK MARKET SERVICES LIMITED
Level 12 QV1 Building, 250 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000
1300 554 474
Company Executives
- Name
- Position
- Salary
- Liz Dallimore
- Executive Director, Chief Executive Officer,Managing Director
- --
- Geoffrey (Geoff) Richard Pocock
- Non-Executive Chairman of the Board
- --
- Terrence (Terry) Charles Budge
- Non-Executive Director
- --
- Samantha (Sam) South
- Executive Director
- --
- Elizabeth (Liddy) McCall
- Non-Executive Director
- --
- Emma Waldon
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg